CRO Services for CNS Oriented NHP Studies

11:40 am - Thursday 5th February 2026

  • Modeling of PD and AD pathology in macaques for therapeutic efficacy testing  
  • MRI and PET imaging capabilities related to pathology and efficacy endpoints  
  • Biodistribution study designs with CNS dosing, biomarker quantification, safety/pathology and pharmacodynamic readouts
  • Behavior and cognitive assessment capabilities

Speakers:

CTO
Kunming Biomed International (KBI)